for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

my own business experience tells me thhat the truism holds true.
as for SEO's fate, i shall not crow if it goes belly up .... not my style.
i actually suspect it will limp along on its zimmer frame for a little while yet, the sp stumbling up a bit and then down again, with the probability of the downward trend continuing.

From my business experience, Eric, the good deals are signed quickly. The deals that take an age to knock into shape are usually less productive. Thats my experience.

But, hey, deals are imminent now - haven't you read the September RNS?

I can see a SPrice of 50p.








Perhaps after a consolidation or two.

Fred. You could well be right about a consolidation - Schroders probably will not be comfortable with the penny share status. Not necessarily good for the sp but could come with the results with a 'solid' business forecast (no, cynic, that doesn't mean 'crap'!).

I reckon SEO may top the inverse VTP ratio. Value to Posts is about 1500! The answer might be to increase the post volume - 100 per day would imply a cap of about 90m by year-end!

First time i've seen these off the front page !!!!
not a post all day.

according to Barrie Hozier, Stanelco's finance director.

We expect that starch capsules will displace most of the existing gelatine capsules from the capsule market to become the new standard, he commented, whilst predicting that the market opportunity is upwards of a billion dollars.




Re: Stanelco products now appear on Wal-Mart's suppliers 'sustainability' demo Website, 60,000 visitors !
Posted by: Mini Buffett (IP Logged)
Date: January 2, 2007 06:13PM


Back in 2003 when the Ingel deal was signed with Isracaps, this article was published, and the comments must apply equally to the Carclo capsules, maybe more so as there are some new options with the Carclo capsules that weren't available with the Ingel capsules :wink:



27/10/2003 - UK-based Stanelco has licensed rights to a non-gelatine encapsulation process developed by its subsidiaries Adept Polymers and Stanelco Fibre Optics to Isracaps, an Israeli company.

The news comes hard on the heels of a patent dispute between Stanelco and BioProgress, another UK firm specialising in non-gelatine encapsulation. Neither company was available to comment on what bearing the outcome of the lawsuit may have on the licensing deal before this article went to press.
Isracaps gains rights to use the starch-based process in its home market to manufacture capsules in which drugs, vitamins, food additives and other substances can be preserved in liquid form.

In a statement, the Israeli company noted that encapsulation is currently carried out using gelatine, which limits the substance forms that can be encapsulated and is a longer process. Isracap maintains that the starch-based technology developed by Stanelco is 40 per cent cheaper than gelatine-based alternatives.

Yaron Berenholtz, Isracaps' chief executive, said: Presently, less than half the range of available drugs can be packaged in gelatine capsules due to the interaction with the gelatine. The introduction of capsules made from starch, derived from plant sources will open up the drug capsules market and drastically reduce costs."

Israpac was formed with the express purpose of handling the Stanelco, and is still in the process of setting up manufacturing facilities in Israel and recruiting initial staff. It is also in talks with pharmaceutical companies and institutional financial investors, with a view to raising funds and signing a partner for the technology.

Stanelco says that it developed the starch-based process by combining the polymer film expertise of Adept with its own in-house radio-frequency-based sealing technology, stemming from its activities in fibre optics. The company has high hopes for the technology, according to Barrie Hozier, Stanelco's finance director.

We expect that starch capsules will displace most of the existing gelatine capsules from the capsule market to become the new standard, he commented, whilst predicting that the market opportunity is upwards of a billion dollars.

Balamory?

Only about 3 years too late.

Gaz

Have all SEO shareholders left the country in disgust?

An unprecedented lack of posts - 3 days.

Nothing to say either, but had to break the silence!

Oily - still waiting for your SP prediction for 31/12/07

Hallo oily, I guess we are all just hanging on with baited breath!!! Happy new year and good luck to all long term holders. cheers.

boldtrader Suggest you don't bait the breath. May be under water for some time. But may resurface in second quarter. I think right to hold at current level but I also see time to get back in. I am hoping that we might get a moderately encouraging RNS or, perhaps more likely, indications of progress with prelims (last year were 28th February). This could lead to a buying opportunity at lower risk. Well, that's my theory; currently funds seem to be better employed elsewhere. So, good luck to long term holders and otehr interested parties.

Eric

you bait a hook with a maggot, or in BB terms, ramp a share with questionable info (ask maestro; he's an expert!) ...... you hold bated breath!

cynic - quite agree. "Baited breath" sounds somewhat halitotic?

'haliotis' would be better for SEO!

OK boys,I,m just an uneducated boy done half well from the North,if i had been fully educated,most probably would never have put my cash into SEO!! Still never mind,baited or bated cheers to you lot too.

I'm still here... hanging on....praying.....

'Morning all

Somebody posted a mention that Biopac in Australia seemed to using Stanelco's products.

I e-mailed them and this was the reply I received this morning.

Interesting!!

The oily one


Hi ,

Thank you for your enquiry. At the current time, I am unable to provide you
with information relating to our involvement with Stanelco.

Regards


Richard Fine
BioPak
Enviromentally Friendly Solutions
Level 4 Block D 12-24 Talavera Rd
North Ryde NSW 2060
Australia

M +61 405 016 390
T +612 8877 5959
F +612 8877 5999
E rfine@biopak.com.au
W www.biopak.com.au


-----Original Message-----
From: xxxxxxxx@onetel.net
Sent: Tuesday, 9 January 2007 3:20 AM
To: rfine@biopak.com.au
Subject: FEEDBACK FROM WEBSITE




IP Address of Sender: 84.43.xx.xxx
------------------------------------------------
Name :
Email :xxxxxxx@onetel.net

Message :Are you using Stanelco\'s formula for the
manufacture of your starch based biodegradable plastic packaging products?

Thank you in anticipation of your reply.

Regards

xxxxxxxx
------------------------------------------------

Thanks for sharing, Oily.
I read that as we are working with Stanelco, but cannot say anything.
Surely they could have denied it if they were not.
Alan

Still waiting for a reply from SEO with regard to Starpol 3000 FDA approval & Biopak link. Will post reply if it is of any use.